SCHEMBL19687309

SCHEMBL19687309

Cc1nc(-c2cccc(S(=O)(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CCC3CCC3)B(O)O)c2)cs1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.42
▸ HTT P42858 3/20 0.42
▸ HPGD P15428 1/20 0.42
▸ GAA P10253 2/20 0.41
▸ LMNA P02545 4/20 0.41
▸ USP2 O75604 2/20 0.41
▸ PSMB5 P28074 3/20 0.41
▸ PTGES2 Q9H7Z7 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ NPY5R Q15761 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ MMP1 P03956 1/20 0.40
▸ MMP2 P08253 1/20 0.40
▸ MMP9 P14780 1/20 0.40
▸ MMP8 P22894 1/20 0.40
▸ CTSL P07711 2/20 0.40
▸ CTSS P25774 2/20 0.40
▸ CTSK P43235 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3153318 0.93 PSMB5 (0.48) ALDH1A1HTTHPGDGAALMNA
SCHEMBL15195223 0.89 PSMB5 (0.45) ALDH1A1HTTHPGDGAALMNA
SCHEMBL12225904 0.89 PSMB5 (0.45) ALDH1A1HTTHPGDGAALMNA
SCHEMBL16459016 0.83 NPY5R (0.50) ALDH1A1HTTHPGDGAALMNA
SCHEMBL19387801 0.80 PSMB5 (0.45) PSMB5CTSLCTSSCTSKPSMB11
SCHEMBL16458831 0.80 ALDH1A1 (0.47) ALDH1A1HTTHPGDGAALMNA
SCHEMBL19387844 0.75 F2 (0.44) PSMB5MMP1MMP2MMP9MMP8
SCHEMBL19387845 0.74 PSMB5 (0.70) HTTPSMB5MMP1MMP2MMP9
SCHEMBL19686572 0.74 PSMB5 (0.49) PSMB5PSMB11PSMA7PSMB1PSMA1
SCHEMBL3148972 0.74 NPY5R (0.56) PSMB5NPY5RPSMB11PSMA7PSMB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10035811-B2 Derivatives of 1-amino-2-cyclobutylethylboronic acid MILLENNIUM PHARMACEUTICALS, INC. (US) 2018-07-31 — — US disclosed
US-20170349611-A1 DERIVATIVES OF 1-AMINO-2-CYCLOBUTYLETHYLBORONIC ACID TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2017-12-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10035811-B2 Derivatives of 1-amino-2-cyclobutylethylboronic acid PSMB6, PSMB5, PSMB1 ALDH1A1 4010/4885HTT 172/4885HPGD 4256/4885
US-20170349611-A1 DERIVATIVES OF 1-AMINO-2-CYCLOBUTYLETHYLBORONIC ACID PSMB6, PSMB5, PSMB1 ALDH1A1 4010/4885HTT 172/4885HPGD 4256/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback